| Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors J Cros, N Cagnard, K Woollard, N Patey, SY Zhang, B Senechal, A Puel, ... Immunity 33 (3), 375-386, 2010 | 1538 | 2010 |
| Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ER Garrido, ... Arthritis & Rheumatism 46 (8), 2121-2131, 2002 | 1331 | 2002 |
| BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus … DA Isenberg, A Rahman, E Allen, V Farewell, M Akil, IN Bruce, D D'cruz, ... Rheumatology 44 (7), 902-906, 2005 | 715 | 2005 |
| The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide FA Houssiau, C Vasconcelos, D D’Cruz, GD Sebastiani, ... Annals of the rheumatic diseases 69 (01), 61-64, 2010 | 609 | 2010 |
| Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial FA Houssiau, D D'Cruz, S Sangle, P Remy, C Vasconcelos, R Petrovic, ... Annals of the rheumatic diseases 69 (12), 2083-2089, 2010 | 588 | 2010 |
| The hyperferritinemic syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome C Rosário, G Zandman-Goddard, EG Meyron-Holtz, DP D’Cruz, ... BMC medicine 11, 1-11, 2013 | 568 | 2013 |
| Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ... Arthritis & rheumatism 50 (12), 3934-3940, 2004 | 475 | 2004 |
| The efficacy and safety of abatacept in patients with non–life‐threatening manifestations of systemic lupus erythematosus: results of a twelve‐month, multicenter, exploratory … JT Merrill, R Burgos‐Vargas, R Westhovens, A Chalmers, D D'cruz, ... Arthritis & Rheumatism 62 (10), 3077-3087, 2010 | 437 | 2010 |
| The prevalence and associations of fatigue in systemic lupus erythematosus CM Tench, I McCurdie, PD White, DP D'Cruz Rheumatology 39 (11), 1249-1254, 2000 | 418 | 2000 |
| The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults C Gordon, MB Amissah-Arthur, M Gayed, S Brown, IN Bruce, D D’Cruz, ... Rheumatology 57 (1), e1-e45, 2018 | 401 | 2018 |
| Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined … S Manzi, J Sánchez-Guerrero, JT Merrill, R Furie, D Gladman, SV Navarra, ... Annals of the rheumatic diseases 71 (11), 1833-1838, 2012 | 399 | 2012 |
| BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis E Ntatsaki, D Carruthers, K Chakravarty, D D’Cruz, L Harper, D Jayne, ... Rheumatology 53 (12), 2306-2309, 2014 | 397 | 2014 |
| Autoantibodies to extracellular matrix protein 1 in lichen sclerosus N Oyama, I Chan, SM Neill, T Hamada, AP South, V Wessagowit, ... The Lancet 362 (9378), 118-123, 2003 | 396 | 2003 |
| The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus MP Cancro, DP D’Cruz, MA Khamashta The Journal of clinical investigation 119 (5), 1066-1073, 2009 | 348 | 2009 |
| Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE MA Dooley, F Houssiau, C Aranow, DP D’Cruz, A Askanase, DA Roth, ... Lupus 22 (1), 63-72, 2013 | 318 | 2013 |
| Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis P Alba, L Bento, MJ Cuadrado, Y Karim, MF Tungekar, I Abbs, ... Annals of the rheumatic diseases 62 (6), 556-560, 2003 | 308 | 2003 |
| Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts C Díaz-Lagares, S Croca, S Sangle, EM Vital, F Catapano, ... Autoimmunity reviews 11 (5), 357-364, 2012 | 290 | 2012 |
| Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener's granulomatosis) PMK Lutalo, DP D'Cruz Journal of autoimmunity 48, 94-98, 2014 | 278 | 2014 |
| Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise CM Tench, J McCarthy, I McCurdie, PD White, DP D'Cruz Rheumatology 42 (9), 1050-1054, 2003 | 270 | 2003 |
| BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis C Lapraik, R Watts, P Bacon, D Carruthers, K Chakravarty, D D’Cruz, ... Rheumatology 46 (10), 1615-1616, 2007 | 252 | 2007 |
